Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain

Journal of the American Society of Echocardiography

Volumn 21, Issue 11, 2008, Pages 1257-1264

  Mele, Donato ^a,b   Censi, Stefano ^a,b   La Corte, Renato ^a   Merli, Elisa ^a,b   Lo Monaco, Andrea ^a   Locaputo, Antonella ^a   Ceconi, Claudio ^a,b   Trotta, Francesco ^a   Ferrari, Roberto ^a,b  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b IRCCS   (Italy)

Author keywords

Integrated backscatter; Systemic sclerosis; Tissue Doppler imaging

Indexed keywords

ADULT; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MYOCARDIAL DISEASE; SYSTEMIC SCLEROSIS;

ALGORITHMS; ECHOCARDIOGRAPHY, DOPPLER; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 55049139669     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2008.08.004     Document Type: Article

References (37)

1. D'Angelo W.A., Fries J.F., Masi A.T., and Shulman L.E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46 (1969) 428-440
2. Bulkley B.H., Ridolfi R.L., Salyer W.R., and Hutchins G.M. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53 (1976) 483-490
3. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
4. Follansbee W.P., Miller T.R., Curtiss E.I., Orie J.E., Bernstein R.L., Kiernan J.M., et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 17 (1990) 656-662
5. Fernandes F., Ramires F.J., Arteaga E., Ianni B.M., Bonfa E.S., and Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9 (2003) 311-317
6. Follansbee W.P., Curtiss E.I., Medsger Jr. T.A., Owens G.R., Steen V.D., and Rodnan G.P. Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 77 (1984) 489-496
7. Bulkley B.H., Klacsmann P.G., and Hutchins G.M. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J 95 (1978) 563-569
8. Deswal A., and Follansbee W.P. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22 (1996) 841-860
9. Altman R.D., Medseger T.A., Bloch D.A., and Mitchel B.A. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34 (1991) 403-413
10. Henein M.Y., Cailes J., O'Sullivan C., du Bois R.M., and Gibson D.G. Abnormal ventricular long-axis function in systemic sclerosis. Chest 108 (1995) 1533-1540
11. Urheim S., Edvardsen T., Torp H., Angelsen B., and Smiseth O.A. Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
12. Edvardsen T., Gerber B.L., Garot J., Bluemke D.A., Lima J.A., and Smiseth O.A. Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 106 (2002) 50-56
13. Voigt J.U., Arnold M.F., Karlsson M., Hubbert L., Kukulski T., Hatle L., et al. Assessment of regional longitudinal myocardial strain rate derived from Doppler myocardial imaging indexes in normal and infarcted myocardium. J Am Soc Echocardiogr 13 (2000) 588-598
14. Greenberg N.L., Firstenberg M.S., Castro P.L., Main M., Travaglini A., Odabashian J.A., et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation 105 (2002) 99-105
15. Mimbs J.W., O'Donnell M., Bauwens D., Miller J.W., and Sobel B.E. The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts. Circ Res 47 (1980) 49-58
16. Picano E., Pelosi G., Marzilli M., Lattanzi F., Benassi A., Landini L., et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 81 (1990) 58-64
17. Lythall D.A., Bishop J., Greenbaum R.A., Ilsley C.J., Mitchell A.G., Gibson D.G., et al. Relationship between myocardial collagen and echo amplitude in non-fibrotic hearts. Eur Heart J 14 (1993) 344-350
18. Perez J.E., Miller J.G., Holland M.R., Wickline S.A., Waggoner A.D., Barzilai B., et al. Ultrasonic tissue characterization: integrated backscatter imaging for detecting myocardial structural properties and on-line quantitation of cardiac function. Am J Card Imaging 8 (1994) 106-112
19. Di Bello V., Giorgi D., Talini E., Dell' Omo G., Palagi C., Romano M.F., et al. Incremental value of ultrasonic tissue characterization (backscatter) in the evaluation of left ventricular myocardial structure and mechanics in essential arterial hypertension. Circulation 107 (2003) 74-80
20. Hirooka K., Naito J., Koretsune Y., Irino H., Abe H., Ichikawa M., et al. Analysis of transmural trends in myocardial integrated backscatter in patients with progressive systemic sclerosis. J Am Soc Echocardiogr 16 (2003) 340-346
21. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23 (1980) 581-590
22. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18 (2005) 1440-1463
23. Steen V.D., and Medsger Jr. T.A. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43 (2000) 2437-2444
24. Aguglia G., Sgreccia A., Bernardo M.L., Carmenini E., Giusti De Marle M., Reali A., et al. Left ventricular diastolic function in systemic sclerosis. J Rheumatol 28 (2001) 1563-1567
25. Maione S., Cuomo G., Giunta A., Tanturri de Horatio L., La Montagna G., Manguso F., et al. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 34 (2005) 721-727
26. Plazak W., Zabinska-Plazak E., Wojas-Pelc A., Podolec P., Olszowska M., Tracz W., et al. Heart structure and function in systemic sclerosis. Eur J Dermatol 12 (2002) 257-262
27. Kepez A., Akdogan A., Sade L.E., Deniz A., Kalyoncu U., Karadag O., et al. Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography 25 (2008) 191-197
28. Yu C.M., Sanderson J.E., Marwick T.H., and Oh J.K. Tissue Doppler imaging. A new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49 (2007) 1903-1914
29. Meune C., Allanore Y., Pascal O., Devaux J.Y., Dessault O., Duboc D., et al. Myocardial contractility is early affected in systemic sclerosis: a Tissue Doppler echocardiography study. Eur J Echocardiogr 6 (2005) 351-357
30. D'Andrea A., Stisi S., Bellissimo S., Vigorito F., Scotto di Uccio F., Tozzi N., et al. Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr 6 (2005) 407-418
31. D'Andrea A., Stisi S., Caso P., Uccio F.S., Bellissimo S., Salerno G., et al. Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients. Echocardiography 24 (2007) 587-597
32. Steen V.D., Powell D.L., and Medsger Jr. T.A. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 3 (1988) 196-203
33. Jacobsen S., Ullman S., Shen G.Q., Wiik A., and Halberg P. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28 (2001) 2454-2459
34. Greenland P., and Gaziano J.M. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 349 (2003) 465-473
35. Tzelepis G.E., Kelekis N.L., Plastiras S.C., Mitseas P., Economopoulos N., Kampolis C., et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56 (2007) 3827-3836
36. Hsiao S.H., Lee C.Y., Chang S.M., Lin S.K., and Liu C.P. Right heart function in scleroderma: insights from myocardial Doppler tissue imaging. J Am Soc Echocardiogr 19 (2006) 507-514
37. Vignaux O., Allanore Y., Meune C., Pascal O., Duboc D., Weber S., et al. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 64 (2005) 1268-1273